Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | F10 | P00742 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | STAT6 | P42226 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3384400 | 1.00 | FFAR3 (0.37) | FFAR3F10MMP2PTPN2PTPN1 | |
| SCHEMBL17191519 | 1.00 | FFAR3 (0.37) | FFAR3F10MMP2PTPN2PTPN1 | |
| SCHEMBL5540894 | 0.98 | LMNA (0.37) | FFAR3F10MMP2PTPN2PTPN1 | |
| SCHEMBL2277287 | 0.93 | FFAR3 (0.39) | FFAR3F10MMP2PTPN2PTPN1 | |
| SCHEMBL2277283 | 0.93 | FFAR3 (0.39) | FFAR3F10MMP2PTPN2PTPN1 | |
| SCHEMBL2277288 | 0.93 | FFAR3 (0.39) | FFAR3F10MMP2PTPN2PTPN1 | |
| SCHEMBL21515732 | 0.85 | DPP4 (0.34) | LMNAPOLB | |
| SCHEMBL3152534 | 0.84 | — | — | |
| SCHEMBL11518961 | 0.83 | ALDH1A1 (0.41) | EPHX1 | |
| SCHEMBL3347705 | 0.81 | EPHX1 (0.38) | LMNAEPHX1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3077467-B1 | DRIER COMPOSITION AND USE THEREOF | PPG EUROPE B V (NL) | 2022-11-02 | — | — | EP | claimed |
| US-20190016745-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2019-01-17 | — | — | US | claimed |
| EP-3400231-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS | Technion Research & Development Foundation Limited (IL) | 2018-11-14 | — | — | EP | claimed |
| US-20180282361-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | ELOXX PHARMACEUTICALS LTD. (IL) | 2018-10-04 | — | — | US | claimed |
| US-20180265470-A1 | Drier Composition and Use Thereof | PPG EUROPE B V (NL) | 2018-09-20 | — | — | US | claimed |
| EP-2652025-B1 | DRIER COMPOSITION AND USE THEREOF | PPG EUROPE B V (NL) | 2018-08-22 | — | — | EP | claimed |
| CN-108350014-A | Aminoglycoside derivatives and their use in the treatment of genetic disorders | ELOXX制药有限公司 | 2018-07-31 | — | — | CN | claimed |
| EP-3344641-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | Eloxx Pharmaceuticals Ltd. (IL) | 2018-07-11 | — | — | EP | claimed |
| WO-2017118967-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2017-07-13 | — | — | WO | claimed |
| WO-2017037719-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | ELOXX PHARMACEUTICALS LTD. (IL) | 2017-03-09 | — | — | WO | claimed |
| EP-3122847-A1 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2017-02-01 | — | — | EP | claimed |
| US-20160304747-A1 | Drier Composition and Use Thereof | PPG EUROPE B.V. (NL) | 2016-10-20 | — | — | US | claimed |
| WO-2015148743-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2015-10-01 | — | — | WO | claimed |
| US-6949599-B2 | Polycarbonate polyester molding composition | GENERAL ELECTRIC COMPANY (US) | 2005-09-27 | — | — | US | claimed |
| EP-4692041-A1 | METHOD FOR PRODUCING BIO-DERIVED ESTER COMPOUND, BIO-DERIVED ESTER COMPOUND PRODUCED THEREBY, COSMETIC OR DETERGENT CONTAINING BIO-DERIVED ESTER COMPOUND, AND METHOD FOR REDUCING ODOR OF ESTER COMPOUND | ADEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12514254-B2 | Rosa canina rosehip | UNIVERSITA′ DEGLI STUDI DI CAGLIARI (IT) | 2026-01-06 | — | — | US | disclosed |
| WO-2024204392-A1 | METHOD FOR PRODUCING BIO-DERIVED ESTER COMPOUND, BIO-DERIVED ESTER COMPOUND PRODUCED THEREBY, COSMETIC OR DETERGENT CONTAINING BIO-DERIVED ESTER COMPOUND, AND METHOD FOR REDUCING ODOR OF ESTER COMPOUND | 株式会社ADEKA | 2024-10-03 | — | — | WO | disclosed |
| US-3975431-A | Preparing carboxylic acids from glycidonitriles through enol acylates | THE UPJOHN COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
| US-3972825-A | COBALT, CALCIUM AND ZINC OR ZIRCONIUM CARBOXYLATES | TENNECO CHEMICALS, INC. (US) | 1976-08-03 | — | — | US | disclosed |
| US-3944562-A | ANTIBIOTIC | THE UPJOHN COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180265470-A1 | Drier Composition and Use Thereof | DCTD, AP3D1, TET2 | FFAR3 106/4885F10 501/4885MMP2 3224/4885 |
| US-20190016745-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS | ALPI, MGAM, AASDHPPT | FFAR3 4308/4885F10 3357/4885MMP2 1846/4885 |
| US-20180282361-A1 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | UPF1, AARS1, NUDT21 | FFAR3 4820/4885F10 3923/4885MMP2 4334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.